A detailed history of Marshall Wace, LLP transactions in National Research Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 29,264 shares of NRC stock, worth $560,112. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,264
Previous 71,636 59.15%
Holding current value
$560,112
Previous $1.64 Million 59.37%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$20.61 - $26.17 $873,286 - $1.11 Million
-42,372 Reduced 59.15%
29,264 $668,000
Q2 2024

Aug 14, 2024

BUY
$22.95 - $39.34 $1.64 Million - $2.82 Million
71,636 New
71,636 $1.64 Million
Q1 2022

May 16, 2022

SELL
$36.33 - $42.25 $131,768 - $153,240
-3,627 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$40.05 - $49.0 $145,261 - $177,723
3,627 New
3,627 $151,000
Q1 2021

May 17, 2021

SELL
$42.92 - $54.13 $234,085 - $295,225
-5,454 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$42.75 - $58.98 $233,158 - $321,676
5,454 New
5,454 $233,000

Others Institutions Holding NRC

About NATIONAL RESEARCH CORP


  • Ticker NRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 24,767,100
  • Market Cap $474M
  • Description
  • National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-re...
More about NRC
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.